Treatments for osteoporosis include a variety of medications (bisphosphonates, estrogen/hormone therapy, selective estrogen receptor... Read more »
For those dissatisfied with current drug options for treating osteoporosis: a new medication being developed by Amgen may be making headway... Read more »
While bisphosphonates—Fosamax, Boniva, Actonel, and Reclast— are the most powerful drugs we have to combat osteoporosis, they come with... Read more »
If you want to quit, or at least take a hiatus from, bisphosphonate medication, it is imperative to consult with your doctor to see if this... Read more »
While bisphosphonates—Fosamax, Boniva, et. al.—are certainly the most common osteoporosis drugs, they’re not the only ones you might... Read more »
Using bisphosphonates for more than five years may lead to brittle bones and hip fractures, two new studies suggest. Researchers say the paradox is... Read more »
American Dental Association Response to Concerns about Bisphosphonate Safety In May 2006, the American Dental Association (ADA) posted a brief on... Read more »
The U.S. Food and Drug Administration (FDA) says there is no concrete link between the use of osteoporosis bisphosphonate drugs and certain thigh... Read more »
Women who take oral bisphosphonates for osteoporosis appear to have a reduced risk of some breast cancers, a new study has found. Researchers... Read more »
(With reporting from EurekAlert.org) A new, long-term study of the most popular osteoporosis drug, Fosamax or alendronate sodium, has found extended... Read more »